Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70246254 | 7024625 | 4 | F | 20081228 | 20160919 | 20090616 | 20160923 | EXP | DE-MEDIMMUNE-MEDI-0008428 | ASTRAZENECA | 462.00 | DY | M | Y | 10.00000 | KG | 20160924 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70246254 | 7024625 | 1 | PS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 0 | 140 | MG | INJECTION | /month | |||||||
| 70246254 | 7024625 | 2 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | UNKNOWN | 0 | 140 | MG | INJECTION | /month | ||||||
| 70246254 | 7024625 | 3 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | UNKNOWN | 0 | 130 | MG | INJECTION | /month | ||||||
| 70246254 | 7024625 | 4 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | UNKNOWN | 0 | 150 | MG | INJECTION | /month | ||||||
| 70246254 | 7024625 | 5 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | UNKNOWN | 0 | 147 | MG | INJECTION | /month | ||||||
| 70246254 | 7024625 | 6 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | UNKNOWN | 0 | 170 | MG | INJECTION | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 70246254 | 7024625 | 1 | Antiviral prophylaxis |
| 70246254 | 7024625 | 2 | Antiviral prophylaxis |
| 70246254 | 7024625 | 3 | Antiviral prophylaxis |
| 70246254 | 7024625 | 4 | Antiviral prophylaxis |
| 70246254 | 7024625 | 5 | Antiviral prophylaxis |
| 70246254 | 7024625 | 6 | Antiviral prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 70246254 | 7024625 | HO |
| 70246254 | 7024625 | LT |
| 70246254 | 7024625 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 70246254 | 7024625 | Bradycardia | |
| 70246254 | 7024625 | General physical health deterioration | |
| 70246254 | 7024625 | Multi-organ disorder | |
| 70246254 | 7024625 | Pneumonia | |
| 70246254 | 7024625 | Pseudomonal sepsis | |
| 70246254 | 7024625 | Pulmonary vein occlusion | |
| 70246254 | 7024625 | Respiratory rate increased | |
| 70246254 | 7024625 | Respiratory syncytial virus infection | |
| 70246254 | 7024625 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 70246254 | 7024625 | 1 | 20080916 | 20080916 | 0 | |
| 70246254 | 7024625 | 2 | 20081014 | 20081014 | 0 | |
| 70246254 | 7024625 | 3 | 20081111 | 20081111 | 0 | |
| 70246254 | 7024625 | 4 | 20081209 | 20081209 | 0 | |
| 70246254 | 7024625 | 5 | 20090227 | 20090227 | 0 | |
| 70246254 | 7024625 | 6 | 20090327 | 20090327 | 0 |